Synthesis and evaluation of a macrocyclic bifunctional chelating agent for use with bismuth radionuclides

被引:23
作者
Garmestani, K
Yao, Z
Zhang, M
Wong, K
Park, CW
Pastan, I
Carrasquillo, JA
Brechbiel, MW
机构
[1] NCI, Radioimmune & Inorgan Chem Sect, ROB, DCS, Bethesda, MD 20892 USA
[2] NCI, Ctr Clin, Dept Nucl Med, NIH, Bethesda, MD 20892 USA
[3] NCI, DCS, Metab Branch, NIH, Bethesda, MD 20892 USA
[4] NCI, DBS, Mol Biol Lab, NIH, Bethesda, MD 20892 USA
关键词
bismuth; Bi-205; Bi-206; radioimmunotherapy; bifunctional chelating agent; alpha-therapy;
D O I
10.1016/S0969-8051(00)00203-1
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
The detailed synthesis of the bifunctional chelating agent 2-(p-isothiocyanatobenzyl)-1,4,7,10,13-pentaazacyclopentadecane-N,N',N",N"',N""-pentaacetic acid (BF_PEPA) is reported. This ligand was conjugated to monoclonal antibody B3 and the resultant immunoconjugate radiolabeled with Bi-205,Bi-206. The in vivo stability of the radiolabeled immunoconjugate, and targeting characteristics were determined by biodistribution studies in A431 xenograft tumor-bearing mice sacrificed at 0.5, 1, 2, 4, and 24 hr. Results indicate that BF_PEPA appears to not be a suitable bifunctional chelating agent for sequestering isotopes of Bi(III) for radioimmunotherapy applications. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:409 / 418
页数:10
相关论文
共 47 条
[1]   Intraperitoneal radioimmunotherapy of ovarian cancer with Lu-177-CC49: A phase I/II study [J].
Alvarez, RD ;
Partridge, EE ;
Khazaeli, MB ;
Plott, G ;
Austin, M ;
Kilgore, L ;
Russell, CD ;
Liu, TP ;
Grizzle, WE ;
Schlom, J ;
LoBuglio, AF ;
Meredith, RF .
GYNECOLOGIC ONCOLOGY, 1997, 65 (01) :94-101
[2]  
Bodanszky M., 1993, PRINCIPLES PEPTIDE S, V2nd
[3]   SYNTHESIS OF C-FUNCTIONALIZED TRANS-CYCLOHEXYLDIETHYLENETRIAMINEPENTA-ACETIC ACIDS FOR LABELING OF MONOCLONAL-ANTIBODIES WITH THE BISMUTH-212 ALPHA-PARTICLE EMITTER [J].
BRECHBIEL, MW ;
GANSOW, OA .
JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 1, 1992, (09) :1173-1178
[4]   SYNTHESIS OF 1-(PARA-ISOTHIOCYANATOBENZYL) DERIVATIVES OF DTPA AND EDTA - ANTIBODY LABELING AND TUMOR-IMAGING STUDIES [J].
BRECHBIEL, MW ;
GANSOW, OA ;
ATCHER, RW ;
SCHLOM, J ;
ESTEBAN, J ;
SIMPSON, DE ;
COLCHER, D .
INORGANIC CHEMISTRY, 1986, 25 (16) :2772-2781
[5]  
CAMERA L, 1993, CANCER RES, V53, P2834
[6]   EVALUATION OF A NEW DTPA-DERIVATIVE CHELATOR - COMPARATIVE BIODISTRIBUTION AND IMAGING STUDIES OF IN-111 LABELED B3 MONOCLONAL-ANTIBODY IN ATHYMIC MICE BEARING HUMAN EPIDERMOID CARCINOMA XENOGRAFTS [J].
CAMERA, L ;
KINUYA, S ;
GARMESTANI, K ;
PAI, LH ;
BRECHBIEL, MW ;
GANSOW, OA ;
PAIK, CH ;
PASTAN, I ;
CARRASQUILLO, JA .
NUCLEAR MEDICINE AND BIOLOGY, 1993, 20 (08) :955-962
[7]  
CAMERA L, 1994, J NUCL MED, V35, P882
[8]  
CHAPPELL LL, 2000, IN PRESS BIOCONJUGAT
[9]   Spectrophotometric method for determination of bifunctional macrocyclic ligands in macrocyclic ligand-protein conjugates [J].
Dadachova, E ;
Chappell, LL ;
Brechbiel, MW .
NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (08) :977-982
[10]   Comparison of 225 actinium chelates:: Tissue distribution and radiotoxicity [J].
Davis, IA ;
Glowienka, KA ;
Boll, RA ;
Deal, KA ;
Brechbiel, MW ;
Stabin, M ;
Bochsler, PN ;
Mirzadeh, S ;
Kennel, SJ .
NUCLEAR MEDICINE AND BIOLOGY, 1999, 26 (05) :581-589